Does intracytoplasmic sperm injection increase the risk of gestational diabetes in patients with polycystic over?

Yıl 2021, Cilt: 3 Sayı: 1, 53 - 58, 22.01.2021

Tuğba Gürbüz Nur Dokuzeylül Güngör Arzu Yurci

https://doi.org/10.38053/acmj.837292

Cited By: 5

Öz

Aim: Some studies found that in vitro fertilization (IVF) pregnancies were correlated with an increase in the incidence of gestational diabetes mellitus (GDM). The purpose of this study was to determine the effect of Intracytoplasmic Sperm Injection (ICSI) on the risk of GDM in patients with polycystic over syndrome (PCOS).
Material and Methods: This retrospective study was conducted on 862 women below 40 who applied to gynecology and obstetrics clinic between January 2015 and May 2020. Their BMI was close to each other. They all had a single fetus, and they did not have a diabetes history. The individuals who participated in the study were tested based on 75 g OGTT (oral glucose tolerance test). Demographical characteristics, biochemical findings, and treatment styles were evaluated. Those with GDM history in the previous pregnancy were excluded from the study.
Results: The mean age and BMI of the patients and the differences observed in the control and case groups were not statistically significant (p>0,05). Preparandial (p=0,000), 1st-hour blood glucose levels of OGTT (p=0,000), and 2nd-hour blood glucose levels of OGTT (p=0,000) of the case group were statistically higher than those in the control group (p<0,05).
Conclusion: The confirmation of the indicators which increase the risk of GDM development with PCOS and follow-up in the early pregnancy period might minimize maternal and fetal complications depending on GDM. This study is significant since it investigates the effect of ICSI in patients with PCOS, spontaneous, and IVF pregnancies.

Anahtar Kelimeler

Gestational diabetes;, Polycystic Ovarian Syndrome;, Assisted Reproductive Techniques

Kaynakça

• DeSisto CL, Kim SY, Sharma AJ. Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014; 11: 104.
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34: 62-9.
• Karaçam Z, Çelik D. The prevalence and risk factors of gestational diabetes mellitus in Turkey: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2019; 2: 1-11.
• Karçaaltıncaba D, Çalış P, Öcal N, Özek A, Altuğ İnan M, Bayram M. Prevalence of gestational diabetes mellitus evaluated by universal screening with a 75-g, 2-hour oral glucose tolerance test and IADPSG criteria. Int J Gynaecol Obstet 2017; 138: 148-51.
• Çabuk E, Duru SA, Akal C, Olten B, Eroğlu D, Yanık FF. Maternal characteristics and perinatal outcomes in pregnancies with abnormal 50g oral glucose challenge test and normal 100g oral glucose test results. Poster Presentation. The 4th Congress of the South-East European Society of Perinatal Medicine 20-21 May 2011, Bucharest, Romania.
• Pridjian G, Benjamin TD. Update on gestational diabetes. Obstet Gynecol Clin North Am 2010; 37: 255-67.
• Kakoly N, Moran L, Teede H, Joham A. Cardiometabolic risks in PCOS: A review of the current state of knowledge. Expert Rev Endocrinol Metab 2019; 14: 23-33.
• Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-9.
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012; 33: 981–1030.
• Costello MF, Misso ML, Wong J, et al. The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol 2012; 52: 400-3.
• Persson S, Elenis E, Turkmen S, Kramer MS, Yong EL, Sundstro¨m-Poromaa I. Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study. Human Reproduction 2019; 34: 2052-60.
• Yang X, Li Y, Li C, Zhang W. Current overview of pregnancy complications and live-birth outcome of assisted reproductive technology in mainland China. Fertil Steril 2014; 101: 385-91.
• Zhu L, Zhang Y, Liu Y, et al. Maternal and live-birth outcomes of pregnancies following assisted reproductive technology: a retrospective cohort study. Sci Rep 2016; 6: 35141.
• Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population-based cohort study. BMJ 2011; 343: 6309.
• Rees DA, Jenkins-Jones S, Morgan CL. Contemporary reproductive outcomes for patients with polycystic ovary syndrome: a retrospective observational study. Journal of Clinical Endocrinology and Metabolism 2016; 101: 1664–72.
• Mumm H, Jensen DM, Sørensen JA, et al. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes. Acta Obstet Gynecol Scand 2015; 94: 204-11.
• Aktun HL, Yorgunlar B, Acet M, Aygun BK, Karaca N. The effects of polycystic ovary syndrome on gestational diabetes mellitus. Gynecological Endocrinology 2016; 32 ; 139-42.
• Taylor Ann E. Polycystic Ovary Syndrome Endocrinol Metab Clin North Am 1998; 27: 877-903.
• Futterweit W. Polycystic Ovary Syndrome: Clinical Perspectives and Management. Obstet Gynaecol Survey 1999: 18: 403-13.
• Speroff L, Fritz MA. Clinical Gyneacologic Endocrinology and Infertility. 7 th Edition, 2007: 470-91; 1177-205.
• Devroey P, Bourgain C, Macklon NS,Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab 2004; 15: 84-90.
• Cakiroglu Y, Doger E, Vural F, Kopuk SY, Vural B. Impact of insulin resistance and obesity on intracytoplasmic sperm injection outcomes in young women with polycystic ovary syndrome. North Clin Istanb 2017; 4: 218-24.
• Cozzolino M, Serena C, Maggio L, et al. Analysis of the main risk factors for gestational diabetes diagnosed with International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria in multiple pregnancies. J Endocrinol Invest 2017; 40: 937-43.
• Turhan NO, Seçkin NC, Aybar F and Inegöl I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet 2003; 81: 163-68.
• Ashrafi M, Gosili R, Hosseini R, Arabipoor A, Ahmadi J, Chehrazi M. Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques. Eur J Obstet Gynecol Reprod Biol 2014; 176: 149-52.
• Sir-Petermann T, Hitchsfeld C, Maliqueo M, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 2005; 20: 2122-6.